Artelo Biosciences (ARTL) Current Assets (2014 - 2025)
Artelo Biosciences' Current Assets was $695,000 in Q4 2025, down 72.8% from $2.56 million a year earlier and down 62.0% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Current Assets (2014 - 2025) Analysis & Trends
From Q4 2014 onward, Artelo Biosciences has reported Current Assets for 44 quarters.
- Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -21.5% (FY2020 to FY2025).
- In earlier years, Current Assets was $2.56 million in FY2024 (-76.7%), $10.98 million in FY2023 (-40.1%), $18.32 million in FY2022 (-25.5%) and $24.61 million in FY2021.
- The Q4 2025 figure marks the lowest quarterly Current Assets since Q2 2019.
- Compared with a year earlier, Current Assets has declined for 12 straight quarters, with an average decline of 66.3% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q3 2021 (growth of 609.1%); the worst was Q1 2025 (a decline of 83.1%).
- Per Business Quant data, ARTL's Current Assets in the three quarters before Q4 2025 was $1.83 million (Q3 2025), $2.23 million (Q2 2025) and $1.38 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Artelo Biosciences | 85,673.20 | -5.05 Mn | - | 695,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 695,000.00 |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 10.98 Mn |
| Sep 30, 2023 | 13.43 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Mar 31, 2023 | 16.39 Mn |
| Dec 31, 2022 | 18.32 Mn |
| Sep 30, 2022 | 20.30 Mn |
| Jun 30, 2022 | 22.28 Mn |
| Mar 31, 2022 | 24.59 Mn |
| Nov 30, 2021 | 25.36 Mn |
| Aug 31, 2021 | 10.32 Mn |
| May 31, 2021 | 10.30 Mn |
| Feb 28, 2021 | 11.41 Mn |
API Access
Artelo Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();